⬤ Loading…
MongoDB, Inc.
…
NASDAQ: MDB Technology IT 🔎 Screen
🏹 Trader: 📈 Stage 2 View all →
📈 Stage 2 detected Find the fundamental catalyst → → run Growth Triggers in Ask AI
$29.0B
Market Cap
—
P/E
0.53
PEG
-32.4%
ROCE
-2.5%
ROE
0.02
D/E
-5.5%
OPM
-18.3%
% from 52W High
84
α RS
🔍 MDB is showing a multi-screen setup because it matches 4 of 39 tracked screener presets, RS Rating is 84, and it's within 18.3% of its 52-week high. The main caution: the Fortress Balance preset's Backtest win rate is only 40%. Net: Mixed signal stack, not a recommendation. ? Conviction RS Rating 52W High Backtest
Sources
Conviction 4/39 · RS Rating 84 · 18.3% from 52W high · Backtest win rate 40%
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for MDB including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
— Excellent
— Good
— Average
— Poor
By Category
📊 Peer Medians
About

MongoDB, Inc., together with its subsidiaries, provides general purpose database platform worldwide. The company offers MongoDB Atlas, a hosted multi-cloud database-as-a-service solution; MongoDB Enterprise Advanced, a commercial database server for enterprise customers to run in the cloud, on-premises, or in a hybrid environment; and Community Server, a free-to-download version of its database, which includes the functionality that developers need to get started with MongoDB. It offers professional services comprising consulting and training. The company was formerly known as 10gen, Inc. and changed its name to MongoDB, Inc. in August 2013. MongoDB, Inc. was incorporated in 2007 and is headquartered in New York, New York.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding MDB
View All Superinvestors →
Manager Shares Value % of Fund Period
Jeff Ubben ValueAct Holdings 1.04M $254.0M 4.45% Mar 2026
Steve Cohen Point72 Asset Management 474.4K $116.1M 0.15% Mar 2026
Jim Simons Renaissance Technologies LLC 140.8K $34.5M 0.05% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →
Good quarter Investor Presentation One-Pager? Q1 2027
Revenue
$688M
+25% YoY
Operating Income
$123M
+41% YoY
Operating Margin
18.0%
+2.0pp YoY
Net Income
$112M
+30% YoY
What Went Right
  • Atlas revenue grew 29.4% YoY, adding record $117M year-over-year
  • Customer count increased by 2,500 sequentially to 67,700, with Voyage AI customers more than doubling QoQ
  • Non-GAAP operating margin expanded 2pp YoY to 18%, exceeding guidance
What to Watch
  • EA & other revenue expected to be roughly flat in second half of FY2027 due to tough compares
  • AI adoption still early; agentic workloads have not yet materially moved consumption needle
  • Atlas growth rate is expected to moderate to ~26% in Q2, reflecting larger base and seasonality
Management Guidance
  • Q2 FY2027 revenue: $729M-$734M (23-24% YoY growth)
  • Q2 non-GAAP operating income: $152M-$156M (~21% margin at high end)
  • Full-year FY2027 revenue raised to $2.92B-$2.96B (19-20% growth), operating margin expanded 100-150 bps
Investor Lens
The thesis is stronger after this call. MongoDB delivered a beat-and-raise quarter with accelerating Atlas growth (29.4% YoY), record dollar additions, and expanding margins. Management highlighted early AI wins with Frontier Labs, agents, and AI-native companies, while maintaining disciplined investment. The main caution is the expected flat EA revenue in H2, but the overall momentum in core workloads and emerging AI use cases supports confidence in durable 20%+ growth and rule-of-40 performance.
From investor presentation · AI-generated analysis · Not investment advice
🔒
Premium Feature
Investor Presentation One-Pager — quarterly highlights, what went right/wrong & management guidance
Upgrade to Premium
Already a member? Log in
📈 STRONG Strong beat and raise; Atlas continues to drive outperformance
Revenue
Total revenue reached $688M, up 25% YoY, beating the high end of guidance. Atlas revenue grew 29.4% YoY to $516M (75% of total), adding a record $117M year-over-year. EA and other revenue grew 13% YoY to $171M, driven by enterprise expansions.
Profitability
Non-GAAP net income was $112M ($1.32 per share), up from $86M ($1.00) a year ago. GAAP net income was $4.4M, marking the second consecutive quarter of GAAP profitability.
Margins
Non-GAAP operating margin expanded 2pp YoY to 18%, benefiting from revenue strength and cost discipline. Total non-GAAP gross margin was 74.5%, up ~40 bps YoY, but down ~100 bps QoQ due to product mix and seasonality.
Balance Sheet
Cash and short-term investments totaled $2.4B. Operating cash flow was $202M, free cash flow $198M, both nearly doubling YoY. The company spent $100M on share repurchases and $58M on employee RSU tax settlements.
Key Risks
Management flagged that Atlas growth may moderate to ~26% in Q2 due to larger base. EA revenue is expected to be flat in H2 FY2027 due to tough prior-year compares. AI momentum is still early, and agentic workloads have not yet become a material consumption driver.
Outlook
For Q2 FY2027, revenue guided $729M-$734M (23-24% growth). Full-year revenue raised to $2.92B-$2.96B (19-20% growth), with non-GAAP operating margin expanding to ~20% at the high end, targeting rule-of-40 performance.
Generated by AI · Q1 2027 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q1 2027 Q1 2027 2026-05-28
Q1 revenue grew 25% year-over-year to $688M, led by Atlas and strong AI adoption. Guidance for fiscal 2027 was raised, with Atlas expected to drive continued growth and profitability, supported by new leadership and strategic acquisitions.
Q4 2026 Q4 2026 2026-03-02
Q4 revenue grew 27% year-over-year to $695M, led by strong Atlas and non-Atlas performance, with major customer wins and record new ARR. FY27 guidance calls for 16–18% revenue growth and continued margin expansion, while AI adoption remains an emerging driver.
Q3 2026 Q3 2026 2025-12-01
Q3 saw 19% revenue growth to $628M, with Atlas accelerating to 30% year-over-year growth and now 75% of revenue. Raised guidance for Q4 and FY26, with strong operating margins and free cash flow, while positioning for AI-driven expansion and continued enterprise modernization.
Q2 2026 Q2 2026 2025-08-26
Q2 revenue grew 24% year-over-year to $591M, with Atlas accelerating to 29% growth and comprising 74% of total revenue. Full-year guidance was raised across revenue, operating margin, and net income, driven by strong enterprise workloads and robust customer additions, while AI adoption remains an emerging but not yet material driver.
Q1 2026 Q1 2026 2025-06-04
Revenue grew 22% YoY to $549M, with Atlas up 26% and strong customer additions. FY2026 guidance was raised for revenue and operating margin, and the share repurchase program expanded to $1B. Atlas momentum, AI investments, and robust self-serve growth position the company for continued success.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.